Cellebrite DI Ltd. (NASDAQ:CLBT) Given Average Recommendation of “Buy” by Brokerages
Shares of Cellebrite DI Ltd. (NASDAQ:CLBT – Get Free Report) have been given an average rating of “Buy” by the seven research firms that are currently covering the stock, MarketBeat.com reports. Seven analysts have rated the stock with a buy recommendation. The average twelve-month price objective among brokerages that have issued ratings on the stock […]
Shares of Cellebrite DI Ltd. (NASDAQ:CLBT – Get Free Report) have been given an average rating of “Buy” by the seven research firms that are currently covering the stock, MarketBeat.com reports. Seven analysts have rated the stock with a buy recommendation. The average twelve-month price objective among brokerages that have issued ratings on the stock […]
